N,N-Dimethylethanaminium

N,N-Dimethylethanaminium

SCHEMBL446423

CCC=C(C)C(N)=O.CCN(C)C

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CHRM1 P11229 2/20 0.30
CHRM2 P08172 1/20 0.30
CHRM4 P08173 1/20 0.30
CHRM5 P08912 1/20 0.30
CHRM3 P20309 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
N,N-Dimethylethanaminium SCHEMBL3024639 1.00 CHRM1 (0.30) CHRM1CHRM2CHRM4CHRM5CHRM3
Trimethylammonium SCHEMBL444001 0.91 TDP1 (0.32)
Trimethylammonium SCHEMBL3037482 0.91 TDP1 (0.32)
Trimethylammonium SCHEMBL28049015 0.89 TDP1 (0.31)
Trimethylammonium SCHEMBL3296121 0.89 TDP1 (0.31)
Trimethylammonium SCHEMBL3296379 0.89 TDP1 (0.31)
SCHEMBL297210 0.89
SCHEMBL297211 0.89
SCHEMBL14982855 0.89
SCHEMBL28049103 0.87 CHRM2 (0.32) CHRM1CHRM2CHRM4CHRM5CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1825884-B1 Brightening and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-08-16 EP claimed
EP-1813260-B1 Bleaching and/or colouring agent with reduced potential for irritation HENKEL AG & CO KGAA (DE) 2017-05-31 EP claimed
US-20160199282-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION HENKEL AG & CO. KGAA (DE) 2016-07-14 US disclosed
US-20140271520-A1 NON-WEIGHING HAIR PREPARATIONS HENKEL AG & CO., KGAA (DE) 2014-09-18 US disclosed
US-8802068-B2 Non-weighing hair preparations HENKEL AG & CO. KGAA (DE) 2014-08-12 US disclosed
US-20120251473-A1 NON-WEIGHING HAIR PREPARATIONS HENKEL AG & CO. KGAA (DE) 2012-10-04 US disclosed
US-20120201773-A1 UNENCUMBERING HAIR TREATMENT PRODUCT HENKEL AG & CO. KGAA (DE) 2012-08-09 US disclosed
US-20120060856-A1 Cosmetic Composition and Reshaping Method for Keratinic Fibers HENKEL AG & CO. KGAA (DE) 2012-03-15 US disclosed
US-20100215604-A1 Cosmetic Compositions with Chitosan and Silicone Elastomers HENKEL AG & CO. KGAA (DE) 2010-08-26 US disclosed
US-20090304620-A1 HAIR TREATMENT PRODUCTS COMPRISING POLYMERS HENKEL AG & CO. KGAA (DE) 2009-12-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090304620-A1 HAIR TREATMENT PRODUCTS COMPRISING POLYMERS ASS1, SRM, COL1A1 CHRM1 2295/4885CHRM2 2908/4885CHRM4 4663/4885
US-20100215604-A1 Cosmetic Compositions with Chitosan and Silicone Elastomers HDAC10, HDAC1, HDAC3 CHRM1 2879/4885CHRM2 2774/4885CHRM4 4182/4885
US-20120201773-A1 UNENCUMBERING HAIR TREATMENT PRODUCT POLR1C, SPTAN1, SMURF1 CHRM1 4703/4885CHRM2 4749/4885CHRM4 4785/4885
US-20120251473-A1 NON-WEIGHING HAIR PREPARATIONS KRT18, KRTCAP2, PSMB10 CHRM1 4185/4885CHRM2 3893/4885CHRM4 4441/4885
US-20120060856-A1 Cosmetic Composition and Reshaping Method for Keratinic Fibers H1-0, H1-3, H1-2 CHRM1 82/4885CHRM2 23/4885CHRM4 73/4885
US-20160199282-A1 PERFORMANCE-ENHANCED HAIR TREATMENT COMPOSITION KRT18, YWHAZ, PHYKPL CHRM1 4211/4885CHRM2 3947/4885CHRM4 4259/4885
US-20140271520-A1 NON-WEIGHING HAIR PREPARATIONS KRT18, KRTCAP2, PSMB10 CHRM1 4185/4885CHRM2 3893/4885CHRM4 4441/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.